Literature DB >> 3190449

Tumour induction in mice following exposure to aristolochic acid.

U Mengs1.   

Abstract

After treatment for 3 weeks with aristolochic acid (AA) in daily doses of 5.0 mg/kg mice were kept under observation for approximately 1 year. During this period papillomatous changes occurred in the forestomach. At a later stage, squamous cell carcinomas were observed in all the animals. In one case, an adenocarcinoma was found in the glandular stomach. In addition, malignant lymphomas were found, as well as adenomas of the kidneys, carcinomas of the lungs, and haemangiomas of the uteri.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3190449     DOI: 10.1007/bf00293699

Source DB:  PubMed          Journal:  Arch Toxicol        ISSN: 0340-5761            Impact factor:   5.153


  1 in total

1.  On the histopathogenesis of rat forestomach carcinoma caused by aristolochic acid.

Authors:  U Mengs
Journal:  Arch Toxicol       Date:  1983-03       Impact factor: 5.153

  1 in total
  28 in total

1.  Upper urinary tract urothelial cancers: where it is A:T.

Authors:  Magali Olivier; Monica Hollstein; Heinz Hans Schmeiser; Kurt Straif; Christopher P Wild
Journal:  Nat Rev Cancer       Date:  2012-08       Impact factor: 60.716

2.  Genetic loci that affect aristolochic acid-induced nephrotoxicity in the mouse.

Authors:  Thomas A Rosenquist
Journal:  Am J Physiol Renal Physiol       Date:  2011-03-23

Review 3.  Aristolochic acid nephropathy: epidemiology, clinical presentation, and treatment.

Authors:  Randy L Luciano; Mark A Perazella
Journal:  Drug Saf       Date:  2015-01       Impact factor: 5.606

4.  Physiological and molecular characterization of aristolochic acid transport by the kidney.

Authors:  Kathleen G Dickman; Douglas H Sweet; Radha Bonala; Tapan Ray; Amy Wu
Journal:  J Pharmacol Exp Ther       Date:  2011-05-05       Impact factor: 4.030

5.  Cytochrome P450 1A2 detoxicates aristolochic acid in the mouse.

Authors:  Thomas A Rosenquist; Heidi J Einolf; Kathleen G Dickman; Lai Wang; Amanda Smith; Arthur P Grollman
Journal:  Drug Metab Dispos       Date:  2010-02-17       Impact factor: 3.922

6.  Renal toxicity of aristolochic acid in rats as an example of nephrotoxicity testing in routine toxicology.

Authors:  U Mengs; C D Stotzem
Journal:  Arch Toxicol       Date:  1993       Impact factor: 5.153

7.  Sulfotransferase-1A1-dependent bioactivation of aristolochic acid I and N-hydroxyaristolactam I in human cells.

Authors:  Keiji Hashimoto; Irina N Zaitseva; Radha Bonala; Sivaprasad Attaluri; Katherine Ozga; Charles R Iden; Francis Johnson; Masaaki Moriya; Arthur P Grollman; Viktoriya S Sidorenko
Journal:  Carcinogenesis       Date:  2016-04-18       Impact factor: 4.944

Review 8.  Aristolochic acid and 'Chinese herbs nephropathy': a review of the evidence to date.

Authors:  Jean-Pierre Cosyns
Journal:  Drug Saf       Date:  2003       Impact factor: 5.606

9.  Detoxification of aristolochic acid I by O-demethylation: less nephrotoxicity and genotoxicity of aristolochic acid Ia in rodents.

Authors:  Shinya Shibutani; Radha R Bonala; Thomas Rosenquist; Robert Rieger; Naomi Suzuki; Francis Johnson; Frederick Miller; Arthur P Grollman
Journal:  Int J Cancer       Date:  2010-09-01       Impact factor: 7.396

10.  DNA adducts of aristolochic acid II: total synthesis and site-specific mutagenesis studies in mammalian cells.

Authors:  Sivaprasad Attaluri; Radha R Bonala; In-Young Yang; Mark A Lukin; Yujing Wen; Arthur P Grollman; Masaaki Moriya; Charles R Iden; Francis Johnson
Journal:  Nucleic Acids Res       Date:  2009-10-23       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.